Inflazome

About:

Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes.

Website: http://inflazome.com/#introduction

Twitter/X: inflazome

Top Investors: Forbion Capital Partners, Novartis Venture Fund, Michael J. Fox Foundation, Fountain Healthcare Partners

Description:

Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes. The company's drugs block inflammasome signals, eliminating a root cause of inflammation, enabling healthcare institutions to avail targeted therapies for inflammatory diseases such as Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes. The company was incorporated in 2016 and is headquartered in Dublin, Ireland.